Lithium Carbonate
Sun Pharmaceutical Industries Limited
Lithium Carbonate Tablets USP
FULL PRESCRIBING INFORMATION: CONTENTS*
- WARNING
- LITHIUM CARBONATE DESCRIPTION
- CLINICAL PHARMACOLOGY
- LITHIUM CARBONATE INDICATIONS AND USAGE
- LITHIUM CARBONATE CONTRAINDICATIONS
- WARNINGS
- PRECAUTIONS
- LITHIUM CARBONATE ADVERSE REACTIONS
- OVERDOSAGE
- LITHIUM CARBONATE DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FULL PRESCRIBING INFORMATION
WARNING
Lithium toxicity is closely related to serum lithium levels, and can occur at doses close to therapeutic levels. Facilities for prompt and accurate serum lithium determinations should be available before initiating therapy (see DOSAGE AND ADMINISTRATION).
LITHIUM CARBONATE DESCRIPTION
Inactive Ingredients:
23
CLINICAL PHARMACOLOGY
LITHIUM CARBONATE INDICATIONS AND USAGE
LITHIUM CARBONATE CONTRAINDICATIONS
WARNINGS
see DOSAGE AND ADMINISTRATION
PRECAUTIONS
General
see DOSAGE AND ADMINISTRATION
Information for the patients
Drug interactions
Combined use of haloperidol and lithium.
Non-steroidal anti-inflammatory drugs (NSAIDS)
Pregnancy, Teratogenic Effects
WARNINGS
Nursing Mothers
Usage in Children
LITHIUM CARBONATE ADVERSE REACTIONS
Lithium toxicity
Neuromuscular
Central Nervous System
Cardiovascular
Neurological
Gastrointestinal
Genitourinary
Dermatologic
Autonomic Nervous System
Thyroid Abnormalities
3 4See PRECAUTIONS
EEG Changes
EKG Changes
Miscellaneous
Miscellaneous reactions unrelated to dosage are:
OVERDOSAGE
ADVERSE REACTIONS
Treatment
LITHIUM CARBONATE DOSAGE AND ADMINISTRATION
Acute Mania
Long-term Control
N.B.
HOW SUPPLIED
Lithium Carbonate Tablets USP
Store and Dispense:
Caraco Pharmaceutical Laboratories, Ltd.
Sun Pharmaceutical Ind. Ltd.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 62756-430-88
Lithium Carbonate Tablets USP
300 mg
Rx only
100 TABLETS
Sun Pharmaceutical Industries Ltd.
Lithium CarbonateLithium Carbonate TABLET
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!